# Area of Interest under PHO ISO: ASCENT-IBO

Canonical: https://abierto.us/opportunities/arpahsn26158

- Solicitation number: ARPA-H-SN-26-158
- Notice type: Special notice
- Status: Closed. Deadline was October 15, 2026 at 5:00 PM EDT
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: Advanced Research Projects Agency for Health (Arpa-H) (75N992)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: AN13 Health R&D Services; Health Care Services; Experimental Development
- First posted: August 5, 2026
- Last posted: August 5, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/844c5c24112a40299cf403ea8fc083c2/view

## Description

See attached Special Notice ARPA-H-SN-26-158:

**Accelerating Safe Clinical Evaluation of Novel Treatments:** Ibogaine for Better outcomes in OUD (ASCENT-IBO) This Special Notice builds upon ARPA-H-SN-26-156 and includes details related to a Proposers’ Day event.

## Publications

- August 5, 2026: Special notice, due October 15, 2026 at 5:00 PM EDT. Notice 844c5c24112a40299cf403ea8fc083c2. https://sam.gov/workspace/contract/opp/844c5c24112a40299cf403ea8fc083c2/view

## Points of contact

- SEE DESCRIPTION SECTION, do_NOT_use_THIS_email_ADDRESS@arpa-h.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/arpahsn26158.